Chief, Developmental Therapeutics Branch and Laboratory
of Molecular Pharmacology,
NCI at National Institutes of Health, Bethesda
Specialty
Molecular Oncology Pharmacology
Title
Precision Medicine with Topoisomerase Inhibitors and Implication of the Innate Immune Response Mediated by Schlafen 11 (SLFN11)
